Articles Authored by Greg Cima
Irish Diagnostics Firm Altratech Aims to Enter Molecular, POC Testing Space by Supplanting PCR
The Ireland-based firm said its inexpensive capacitance-based assays deliver "molecular detection by proxy," providing rapid, multiplex, quantitative results.
In a bid to expand recognition and treatment of alpha-1 antitrypsin deficiency, a cause of COPD, Grifols is making its over-the-counter genetic test available for free.
Lucira Health won't be the last COVID-19-focused firm to face bankruptcy, layoffs, or stock price declines, as "COVID cash" dries up, experts said.
PerkinElmer Revenues Drop 28 Percent in Q4 on COVID-19 Test Decline
The firm's earnings slid as COVID-19 testing revenues plummeted to $31 million in Q4 2022 from $336 million a year ago.
Siemens Healthineers Q1 Dx Revenues Fall 21 Percent; Firm Strikes Lab Analyzer Deal With Unilabs
A decline in demand for rapid COVID-19 antigen tests dragged on the company's diagnostics division while lockdowns in China reduced routine testing.
Hologic Fiscal Q1 Revenues Fall 27 Percent as COVID-19 Assay Sales Continue Slide
The firm beat predictions for the quarter on the strength of its other molecular diagnostics business, and it predicts double-digit revenue growth for the year.
The firm is developing a shoebox-size gas chromatography instrument that could be used for routine screenings and critical illness detection and monitoring.
The Cue Health-sponsored ImmunoCare study is testing the value of giving immunocompromised people at-home tests, telemedicine, and prescription delivery.
Hologic Aims to Expand Global Reach With Focus on Women's Health
At the JP Morgan Healthcare conference, CEO Steve MacMillan especially noted Africa as an underserved market for women's health.
Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.